Introduction to 6 8 2015 Session 1 Discussion
Exploring 6 8 2015 Session 1 Discussion reveals several interesting facts. Session 1 Discussion
6 8 2015 Session 1 Discussion Comprehensive Overview
Strengths and limitations of traditional pre-clinical models Beverly Teicher, National Cancer Institute. Advantages and experiences with trials that include animal patients Chand Khanna, National Cancer Institute. Michael Kastan (Duke) Planning Committee Chair.
Panelists field questions from the audience.
Summary & Highlights for 6 8 2015 Session 1 Discussion
- Panelists field questions from the audience.
- Discussion
- Discussion
- Session
- Session 1
Stay tuned for more updates related to 6 8 2015 Session 1 Discussion.